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1. Introduction
Asthma is one of the most common chronic diseases in the world. It is estimated that around
300 million people in the world currently have asthma [1]. Asthma has become more common
in both children and adults around the world in recent decades. The increase in the prevalence
of this disease has been associated with an increase in atopic sensitization, and is paralleled
by similar increases in other allergic disorders such as eczema and rhinitis [1]. The rate of
asthma increases as communities adopt western lifestyles and become urbanized. With the
projected increase in the proportion of the world's population that is urban from 45% to 59%
in 2025, there is likely to be a marked increase in the number of asthmatics worldwide over
the next two decades [2]. Nevertheless the prevalence of asthma in rural developing countries
has been under estimated for many years [3]. In many areas of the world persons with asthma
do not have access to basic asthma medications or medical care and are not included in any
statistical survey [4]. Increasing the economic wealth and improving the distribution of re‐
sources between and within countries represent important priorities to enable better health
care to be provided. The burden of asthma in many countries is of sufficient magnitude to
warrant its recognition as a priority disorder in government health strategies. Particular re‐
sources need to be provided to improve the care of disadvantaged groups with high morbidity.
Resources also need to be provided to address preventable factors [1, 2]. It is estimated that
asthma accounts for about 1 in every 250 deaths worldwide. Many of the deaths are prevent‐
able, being due to suboptimal long-term medical care and delay in obtaining help during the
final attack. The economic cost of asthma is considerable both in terms of direct medical costs
(such as hospital admissions and cost of pharmaceuticals) and indirect medical costs (such as
time lost from work and premature death) [1]. Therefore there is a greater understanding of
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the factors that cause asthma which may lead to novel public health and pharmacological
measures to reduce the prevalence of asthma seems to be a worldwide priority.
Among the many factors influencing the prevalence of asthma in developing countries from
the tropics are geo-helminthic infections [3], including those caused by Ascaris lumbricoides,
Trichuris trichiura and hookworm (Ancylostoma duodenale and Necator americanus). These infec‐
tions have a worldwide distribution being present in almost all geographic and climatic re‐
gions. The prevalence of these infections tends to be highest in warm, moist climates; also they
are closely correlated with poor environmental hygiene and lack of access to health services
[5, 6]. The estimated global prevalence of A. lumbricoides, T. trichiura and hookworm are 1.5
billion, 1.3 billion and 900 million, respectively, and greater than 2 billion humans are infected
with at least one of these parasites [5, 6]. Hookworm is transmitted through skin contact with
free-living larvae in the soil, whereas A. lumbricoides and T. trichiura are transmitted through
ingestion of embryonated eggs from the environment. A. lumbricoides and hookworm undergo
a phase of larval migration through the lungs, whereas T. trichiura has a purely enteric life
cycle. Infections with A. lumbricoides and T. trichiura peak in prevalence and intensity between
5 and 15 years of age in endemic areas and there is a decline in both epidemiological parameters
in adulthood [5, 6]. Morbidity, including important effects on growth, nutrition and mental
development in childhood tends to be greatest in heavily infected children and vulnerable
adults (e.g. women of child-bearing age) with long exposure histories [6]. Epidemiological
observations have provided evidence that geo-helminthic infections can influence the devel‐
opment of allergic diseases such as asthma. Different studies carried out mostly in rural areas
from different countries have shown that infection by intestinal helminths stimulates the risk
of asthma [7, 8, 9], whereas other studies in similar populations, have shown an inverse asso‐
ciation between asthma and the infection of these parasites [10]. Whether helminthic infections
increase or decrease the risk of asthma may depend on environmental factors determining
time of exposure and the prevalence and intensity of the infection [3]. On the other hand the
individual capacity of the immune system to recognize certain allergenic components of the
many molecules involved in host parasite interactions as well as the possible role of parasite
mediators to inhibit inflammatory processes may be important aspects in the modulation of
the pathogenesis of asthma by these parasites.
2. Immunological aspects of asthma
It  is  well  accepted that asthma is  a chronic inflammatory disorder of  the bronchial  mu‐
cosa [11].  The symptoms include chest tightness,  wheeze, and cough, and often variable
obstruction  of  airflow  through  the  bronchi.  The  clinical  manifestation  of  asthma  is  the
result  of  three events  within the airways:  reversible  obstruction,  airway hyper-reactivity
and inflammation.  Among these factors,  airway inflammation is  believed to  play a  ma‐
jor role in the development of the disease [11].
The bronchial inflammation process of asthma is stimulated by cells of the innate immune
system (dendritic cells, mast cells, eosinophils, neutrophils, macrophages and NK-cells) and
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of the adaptive immune system (CD4 + T-lymphocytes, and antigen-specific IgE secreting B-
lymphocytes). The innate and adaptive cells are of Th2 class, secreting the cytokines IL-13 and
IL-4 prominently or responding to these cytokines through their transduction molecule STAT6
[12, 13]. Thus, the input of these cells into the bronchus and the release or secretion of many
mediators (e.g. heparin, reactive lipids or eicosanoids, and enzymes including tryptase and
chitinase) lead to increased permeability of blood vessels and consequent edema, increased
mucus production, and exaggerated smooth muscle contraction [13] causing airflow obstruc‐
tion and the symptoms described above. Also, continued inflammation results in remodeling
of the airway in which it is thought that TGF-β cytokine may drive the metaplasia of the epi‐
thelium, increased vascularity, thickening of the basement membrane, and muscular hyper‐
trophy, leading to lasting airflow obstruction and breathlessness [14, 15].
The induction of adaptive immunity requires antigen-presenting cells (APCs). It is well known
that dendritic cells (DCs) are the main type of APC involved in the induction of Th2 responses
to allergens in asthma [16]. In the lung, DCs can be found throughout the conducting airways,
interstitium, vasculature and pleura and in bronchial lymph nodes. Lung DCs express many
receptors, including Toll-like receptors, Nod-like receptors and C-type lectin receptors up reg‐
ulate the expression of several co-stimulatory molecules (such as CD80 and CD86) and che‐
mokines (such as CCL17 and CCL22) that attract T cells, eosinophils and basophils into the
lungs[16-19]. In humans, monocyte-derived conventional DCs promote Th2 responses by se‐
creting pro-inflammatory cytokines and up-regulating the expression of co-stimulatory mol‐
ecules after antigen stimulation[20] suggesting that lung DCs are necessary for Th2 cell
stimulation during airway inflammation.
As mentioned above, various inflammatory cells, such as basophils, eosinophils and mast cells
are recruited to airways after allergen challenge. Although the main focus in asthma has been
on their roles as inflammatory cells, increasing data suggest that these cells also function as
APCs to initiate or enhance Th2 responses. Basophils, which are circulating granulocytes that
express the high-affinity IgE receptor FcεRI, amplify immediate hypersensitivity responses by
releasing histamine-containing granules and by producing large quantities of IL-4 [13]. More‐
over, several studies have highlighted a crucial previously unknown role for basophils as APCs
that drive Th2 responses through their expression of major histocompatibility complex (MHC)
class II and co stimulatory molecules [21]. Also it has been proposed that MHC class II- de‐
pendent interactions between basophils, which are prominent at sites of allergic inflammation,
and CD4+ T cells may have an important role in the induction of Th2-mediated inflammation
[22, 23]. Another circulating granulocyte that is prominent at sites of allergic inflammation is
the eosinophil. After being stimulated, eosinophils have an important pro-inflammatory role
by producing leukotrienes, as well as Th1 cytokines (interferon-γ and IL-2) and Th2 cytokines
(IL-4, IL-5, IL-10, IL-13 and TNF-α which contribute to airway inflammation [11]. In addition,
eosinophils, like basophils, can also function as APCs [24]. Other relevant components of air‐
way inflammation are the mast cells which express FcεRI and c-Kit and reside in tissues near
mucosal surfaces and blood vessels. Mast cells can initiate immediate hypersensitivity reac‐
tions by de-granulating in response to both adaptive (IgE-mediated) and innate immune sig‐
nals. For example, mast cells can be activated through cross-linking of antigen-specific IgE
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bound to FcεRI [25] or in response to Toll-like receptor agonists, or to cytokines such as IL-33
[26]. In addition to producing histamine and leukotrienes, mast cells produce cytokines (IL-1,
IL-3, IL-4, IL-5, IL-6, IL-8, IL-10, IL-13, IL-16, tumor necrosis factor and transforming growth
factor-β) and chemokines (such as IL-8, lymphotactin, CCL1 (TCA-3), CCL5 (RANTES), CCL2
(MCP-1) and CCL3 (MIP1-α)[27].
An important mediator of airway inflammation is Nitric Oxide (NO) which it is a diffusible
gas that can activate biochemical process either on the same cell that produced it or on neigh‐
boring cells [28]. NO is synthesized from L-arginine by enzyme nitric oxide synthase (NOS),
of which there are three isoforms : NOS I or neuronal NOS (nNOS) was originally isolated
from rat and porcine cerebellum; NOS II or inducible NOS (iNOS) from activated macrophag‐
es; NOS III or endothelial NOS (eNOS) from endothelial cells [28]. High NO levels could be
harmful for asthmatic patients because at elevated concentrations, NO lead to the formation
of reactive nitrogen species (RNS) and subsequent oxidation and nitration of proteins, which
negatively affect protein functions that are biologically relevant to chronic inflammation in the
asthmatic bronchial tissues [28,29]. In asthmatic patients, NO is mainly produced by iNOS
expressed in bronchial epithelial cells and some inflammatory cells [30]. NO is also produced
by neutrophils and macrophages in response to IFN-γ and a second signal provided by a
PAMP ligand or TNF-α. iNOS expression is induced by these signals, this enzyme promotes
the oxidation of the guadino nitrogen of L-arginine, resulting in the production of NO and
citruline [31]. In addition, other mechanisms have been associated with NO production. It has
been demonstrated that the ligation of CD23 (low affinity receptor for IgE FcεRII) on human
macrophages is a strong inducer of NO [32]. Indeed, the cross-linking of CD23 by IgE, (IgE -
immune complexes or by specific monoclonal antibodies) induces pro-inflammatory response,
including NO production [33]. Therefore, allergic sensitization inside the lower airways may
account for NO production. In this context, it has been reported that aeroallergen sensitization
correlated with exhaled NO (eNO) in mild to moderated asthmatic subjects [34]. Also, the late-
phase influx of eosinophils may contribute to NO production at the respiratory mucosa.
3. Stimulation of airway inflammation by helminths parasites
It is important to point out that there are close similarities between the allergic inflammatory
responses stimulated in the host by environmental allergens (described above) with the im‐
mune responses elicited by parasite antigens. Gut inflammation stimulated by intestinal nem‐
atode also include innate (mastocytes, basophils and eosinophils) and adaptive cells of Th2
class which secret preferentially IL-13 and IL-4 cytokines. Pro- inflammatory cells like masto‐
cytes and eosinophils stimulated by these cytokines may release many mediators (heparin,
reactive lipids or eicosanoids, and enzymes including tryptase and chitinase) leading to in‐
creased permeability of blood vessels, increased mucus production and smooth muscle con‐
traction [35]. Also, inflammation induced by most helminths in the host is associated with NO
production through somatic and excretory-secretory antigens of adult worm and larvae [36-
40]. These mechanisms may contribute to make a hostile microenvironment in the gut for the
parasites promoting worm expulsion.
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The capacity of helminths, to stimulate inflammatory responses has been well documented
and they are probably related to the complex lifecycle and the antigenic composition of this
nematode. For example, there is evidence that after penetration of the intestinal mucosa A.
suum larvae migrate to the liver, inducing the formation of granulomas, extensive inflamma‐
tion and tissue injury [41]. Surviving larvae reach the lungs and generate an inflammatory
infiltrate in the airways dominated by severe per-alveolar eosinophilia [41, 42]. Pulmonary
eosinophilia due to the passage of helminth larvae through the lungs is referred to as Loeffler’s
syndrome [43]. Eosinophilic pulmonary infiltrates and respiratory symptoms due to A. lum‐
bricoides or A. suum are generally part of a self-limited process due to the transient nature of
larval passage through the lungs in the Ascaris life cycle [44]. The majority of patients remain
asymptomatic, however 8 to 15% of infected individuals display morbidity, with respiratory
symptoms occurring 9 to 12 days after the ingestion of eggs and lasting 5 to 10 days [45, 46].
Symptoms may include cough, dyspnea, wheeze, and hemoptysis and may progress to frank
respiratory distress [43]. Peripheral eosinophilia is often present at the onset of symptoms, but
the peak level of eosinophilia will have a delay of several days from presentation [47, 48]. Also,
Strongyloides stercoralis may cause pulmonary symptoms and infiltrates as a manifestation of
chronic infection or as a result of hyper-infection in immune-compromised hosts [49]. The
unique life cycle of S. stercoralis allows a chronic infection of extended duration to occur due
to the ability of new filariform larvae to continuously infect the human host through the per‐
ianal skin or bowel mucosa [50]. Patients with chronic infection may have repeated episodes
of fever and pneumonitis that may be mistaken for recurrent bacterial pneumonias [51]. Eo‐
sinophilia, though often absent during the acute episodes, may occur during the intervening
period between episodes [51]. Pulmonary involvement of strongyloidiasis has been reported
as an asthma mimic.
The mechanisms by which these parasites induce airway inflammation are still not well elu‐
cidated. High levels of polyclonal and specific IgE against adult stages of the parasite are a
characteristic of A. lumbricoides infection [52]. It has been shown that Ascaris can induce allergic
sensitization in animal models [42] and in human beings, including immediate cutaneus hyper-
reactivity [52] and airway response after aerosol challenge with parasite extracts [53] suggest‐
ing the presence of an allergenic component on the stimulation of the respiratory symptoms
by these parasites. Helminths harbor an arsenal of many pro- allergenic molecules which may
be involved in airway inflammatory processes. One of the most studied is the A. lumbricoides
body fluid antigen -1 (ABA-1) [54-57] which constitutes the most important of the group of
antigens of the denominated family of nematode polyprotein allergens (NPA) for its capacity
to stimulate strong IgE responses [58]. Recognition of ABA-1 may have a genetic basis [59,
60]. For example, evidences from studies carried out in Colombian endemic areas have shown
that polymorphisms of LIG4 and TNFSF13B of the 13q33 region are associated with high levels
of specific IgE to ABA-1 in A. lumbricoides infected children [60, 61]. However, the possible role
of this allergen in airway inflammation remains unclear. Another important allergenic com‐
ponent of helminths is tropomyosin, which is a microfilament associated protein present in all
eukaryotic cells, essential in the process of muscle work, proper action of the movement ap‐
paratus and the basic functionality of filaments within the cytoskeleton [62]. There is a high
degree of homology among tropomyosins even of phylogenetically distant species of inver‐
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tebrates, but not with vertebrate tropomyosins [62]. Invertebrate tropomyosins induce IgE
antibodies and are potent allergens for humans whereas vertebrate ones were reported to be
non-allergenic [62, 63]. Tropomyosin from A. lumbricoides presents a high degree of sequence
identity to those from other invertebrates, including cockroach, mites, and shrimp [64]. It is
expressed in high levels in the third stage larvae (L3), which is the stage of pulmonary passage
of the parasite and stimulates strongly the production of IgE [64], high positivity to skin prick
tests and histamine release from basophils[64, 65]. A.lumbricoides tropomyosin cross-reacts
with other invertebrate tropomyosins [64] thus enhancing the allergic response to other envi‐
ronmental allergens containing tropomyosin (cockroach, mites, and shrimp) [64, 65] which are
known to induce airway inflammation and asthma [65]. Other important nematode allergens
are chitins, an important component for egg shell integrity and for the structure of the rigid
pharynx, including the buccal cavity and grinder, a specialized cuticle that is shed and re-
synthesized during molting [66]. There is evidence that chitins are involved in Th2 type in‐
flammation. For example, experimental models of asthma using mice have shown that the
intranasal administration of chitin induced an accumulation of eosinophils and basophils [67].
Exposure to chitin also stimulated the alternative activation of macrophages as indicated by
the presence of arginase-expressing cells in the lungs as early as 6 h post intranasal adminis‐
tration of chitin [67]. The recruitment of innate immune cells has shown to be dependent both
upon expression of the high affinity receptor for leucotriene B4, BLT1 and upon the presence
of macrophages [68] suggesting a possible role of chitin in innate immune cell recruitment,
leading to preferential Th2 type responses. In humans, The non-chitinolytic chitinase YKL-40
has been linked to allergic inflammation. YKL-40 levels are elevated in the serum and bron‐
choalveolar lavage (BAL) fluid of asthmatics [69]. Furthermore, increased YKL-40 levels cor‐
related with asthma severity and are elevated in response to allergen challenge. Nematode
proteases which constitute a group of highly evolutionary conserved molecules may exhibit
allergenic properties such as other proteases like house dust mite-derived Der p 1, domestic
cats- derived Fel d1, and fungal allergens [70, 71]. These allergens most often gain access to
host tissues at mucosal sites and in some individuals elicit potent Th2 cytokine responses,
reflecting the hallmarks of the immune response to helminthic infection including eosinophil‐
ia, goblet cell hyperplasia and elevated serum IgE levels as explained above. Basophils which
are innate immune cells able to rapidly secrete IL-4 in vitro following stimulation with anti-
IgE [72] as well as in response to allergens and helminth products [73], would be involved in
the innate sensing of these products which may lead to the initiation of adaptive Th2 cytokine
responses to parasite and/or environmental allergens. For example, immunization of mice with
the cysteine protease allergen, papain, resulted in the transient recruitment of basophils to
lymph nodes that peaked 1 day prior to the peak of IL-4 producing CD4+ T cells [74]. These
papain-elicited basophils within the lymph node were shown to express thymic stromal lym‐
phopoietin (TSLP), an IL-7-like cytokine produced predominantly by epithelial cells and im‐
plicated in CD4+ Th2 cell differentiation [74]. Given their multiple roles in regulating
inflammation, cellular trafficking and epithelial barrier function members of the protease-ac‐
tivated receptor (PAR) family [75] would be potential molecular targets for helminth proteases.
Regardless of the intrinsic allergenic potential of these parasites, there are evidences that active
infection can potentiate the allergic response to non-related antigens. For example, it has been
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shown that antigenic extracts of A. suum potentiate allergic responses to ovalbumin in pigs
(76, 77). It has been also reported that co-administration of hen egg lysozyme with the excre‐
tory ⁄ secretory products of N. brasiliensis in mice results in the generation of egg-lysozyme-
specific lymphocyte proliferation, IL-4 release and IgG1 antibody responses [78]. Furthermore,
it has been shown that unidentified components in the body fluid of A. suum promotes a Th2
response and are adjuvant for specific IgE synthesis to some parasitic allergens like ABA-1 [79].
Because, in addition to this allergen, A. lumbricoides extract has at least 11 human-IgE-binding
components, the adjuvant effect may be more generalized in humans beings, and because of
co-exposure with other environmental allergens, this could happen for cross-reactive and non-
cross-reactive mite allergens [61].These observations are consistent with early studies carried
out in atopic Venezuelan children in which an elevated percentage of skin positivity as well
as high levels of specific serum IgE toward aero-allergens, were found among children infected
with A. lumbricoides compared to their non parasitized counterparts [80].
4. Epidemiological studies showing a positive association between
helminthic infections and asthma
Human immune response to infections with helminths parasites may differ according to the
profile of the infection. As mentioned above, acute or seasonal infections may include primary
infections and repeated or intermittent infections without long period of continuous infections
and may result from infrequent short exposures or intermittent exposure after treatment in
endemic areas [3, 5]. It has been proposed that mild, seasonal helminthic infections stimulate
preferentially inflammatory Th2 type immune responses among parasitized populations [3,
81] characterized by the production of high levels of serum specific IgE and allergic reactivity
toward parasite soluble antigens [82] which may lead to the development of bronchial hyper
reactivity and asthma [83, 84] particularly among atopic individuals [85]. This situation may
be reflected on the increased prevalence of asthma and allergic diseases observed in many low
and middle-income countries [86, 87] undergoing parasite eradication programs [5, 6]. For
example, epidemiological studies carried out in different rural communities in China, have
shown a strong association between Ascaris lumbricoides infection and the development of
asthma [88]. These early results are consistent with a meta-analysis of many of studies inves‐
tigating the association between the presence of geohelminth eggs in stool samples and asthma
providing some evidence for parasite-specific effects [7]. In this work in which thirty-three
studies were taken in account, Ascaris lumbricoides was associated with significantly increased
odds of asthma (OR, 1.34; 95% CI, 1.05–1.71; 20 studies. Further studies carried out in urban
Brazil have shown positive associations between Ascaris lumbricoides infection with recent
wheeze [9] which in turn have been associated to allergic sensitization toward A. lumbricoides
antigens [9]. Other studies carried out in Costa Rica have shown a relationship between sen‐
sitization (defined as a positive IgE) to A. lumbricoides and measures of asthma morbidity and
severity in a population with low prevalence of parasitic infection but high prevalence of par‐
asitic exposure [89]. In this work, a cross-sectional study of 439 children (ages 6 to 14 years)
with asthma was carried out and linear regression and logistic regression were used for the
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multivariate statistical analysis. Sensitization to A. lumbricoides was associated with having
at least 1 positive skin test to allergens (odds ratio, 5.15; 95% CI, 2.36-11.21; P <.0001), increased
total serum IgE and eosinophils in peripheral blood, reductions in FEV (1) and FEV (1)/forced
vital capacity, increased airway responsiveness and bronchodilator responsiveness, and hos‐
pitalizations for asthma in the previous year (odds ratio, 3.08; 95% CI, 1.23-7.68; P = 0.02).
Similarly, it has been also reported that sensitization to A. lumbricoides is associated with
increased severity of asthma among Romanian children [90]. This association was mediated
by a high degree of atopy among the asthmatic children sensitized to A. lumbricoides and
belonging to a population with a low prevalence of helminthiasis. In according to these find‐
ings, studies carried out in Venezuela have shown strong associations between A. Lumbri‐
coides infection and bronchial hyper-reactivity [84]. In this work, 470 school children from
different rural and urban communities were evaluated. It was found that in rural children,
bronchial hyper reactivity was associated with increased specific levels of anti- IgE (p<0.0001)
and skin test positivity toward A lumbricoides antigens (p<0.0001). The percentage of FVE1
predictive values correlated inversely (p<0.0001) with anti-A lumbricoides IgE levels. Elevated
numbers of circulating CD3+CD4+ and CD20+CD23+ cells were found in rural children with
bronchial hyper reactivity compared to their asymptomatic counterparts. They correlated
positively with anti-A lumbricoides IgE levels (p<0.005 and p<0.0001 respectively). In contrast,
in urban children, bronchial hyper reactivity was associated with elevated anti-D pteronissinus
IgE levels (p=0, 0089), skin hyper reactivity towards this aero allergen (p=0,003) and to an
increase in the number of CD3+CD8+ (p<0.0001). These results were consistent with previous
work showing that monthly treatments of parasitized asthmatic children with anti-helminthic
drugs in Venezuela may reduce BHR, symptoms of wheeze and the need for asthma medica‐
tions [2]. Taking together these findings suggest the importance of the atopic condition on the
airway inflammatory response stimulated by these parasites [91]. On the other hand, studies
performed in slum children from endemic areas have shown that parasitized non-asthmatic
children can significant respond to bronchodilator inhalation, and that this response can be
reversed by anti-helminthic treatment suggesting that these parasites cause bronchoconstric‐
tion [92]. Moreover, in a more recent study it was shown that infestation with Ascaris lumbri‐
coides in Brazilian children increased the risk of non-atopic asthma [8] such that children with
high load infestation (≥100 eggs/g) have been found to be five times more likely to have BHR
than children with low load or no infestation [8]. Thus, regardless the atopic status of the
individuals, the link between helminth infestation and non-atopic asthma could be mediated
by the stimulation of transient inflammatory responses by parasite antigens in the pulmonary
phase of the helminth life cycle such as those described according to the Loeffler’s syndrome.
5. The other side of the coin: Chronic helminthic infection may suppress
allergic manifestation and the development of asthma
Because parasites are in constant attack by a range of effective immune mechanisms, they have
developed effective evasion mechanisms which may vary from simple avoidance to a more
active modulation of the immune response in order to establish a non inflammatory environ‐
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ment that allows the parasite to survive. Nematode parasites may enhance survival by direct‐
ing the immune response to that of a less appropriate type. For example interference with the
Th1/-Th2 response balance, the production of high levels of regulatory cytokines such as IL-10
and TGF- β which may lead to a general suppression of T and B cell responses and also mimicry
of host proteins which direct the immune response to tolerance have been reported [93]. It has
been proposed that because these suppressing mechanisms are not parasite- specific, they may
affect the development of allergic reactions in chronically exposed populations [94, 95]. It has
been proposed that the effect of geo-helminths on the suppression of atopy is more important
early in life causing a deviated Th2 immune phenotype that is not changed later in life, after
elimination of the infection [96]. Moreover, there is evidence that maternal helminthic infec‐
tions could affect infant immunity [97, 98] raising the possibility that the immunologic effects
of infection start in the fetus. Further, the inverse association between chronic helminthic in‐
fections and allergic disorders among school children from different rural populations from
Venezuela, Gambia, Ethiopia, Taiwan, Ecuador and Ghana has been well documented [99].
The exact mechanisms by which these parasites dampen allergic responses are probably mul‐
tiple. Chronic helminthic infections may protect against allergic disease because of their pro‐
found suppression of the host immune system, leading to a general T-cell hypo responsiveness
that is facilitated by the activity of regulatory T (Treg) and B cells and the modulation effects
of innate immune cells such as macrophages, dendritic cells (DCs) and local stromal cells,
resulting in an anti-inflammatory environment characterized by increased levels of interleukin
(IL)-10 and transforming growth factor (TGF)-β [100]. In humans, several studies have shown
that Treg cell activity (both by natural CD4+CD25+FoxP3+ and adaptive CD4+IL10+ Tr1 cells)
protects against allergic disease [100,101, 102]. Indeed, successful allergen specific immuno‐
therapy in humans which leads to a reduction in allergic symptoms has been associated with
the emergence of IL-10–producing Treg cells which may be involved in the increase in IgG4
and IgA responses and a simultaneous decrease in IgE [103]. Several studies carried out in
distinct experimental models have revealed a number of active molecules in extracts of hel‐
minths that can modulate the immune system of the host. Early work conducted by Itami et
al [104] have demonstrated that high molecular weight components purified by gel filtration
chromatography from an A. suum adult worm extract were able to suppress the murine anti‐
body production to a bystander antigen. This effect was attributed to a 200 KD a protein com‐
ponent called PAS-1. The protein was affinity purified using a monoclonal antibody (MAIP-1)
produced against high molecular weight suppressive components. Pas-1 was shown to be
capable of down regulating antibody production Th2 secretion; eosinophils recruitment and
airway hyper-responsiveness induced by A. suum allergens [105]. This effect was mediated by
the stimulating capacity of Pas-1 on the production of regulatory cytokines such as IL-10.
Probably the best-characterized groups of helminth immunomodulators are the cystatins (cys‐
teine protease inhibitors) [106] which can inhibit antigen processing and presentation [107],
interfering with antigen-specific T cell responses and the proliferation of T and B cells. They
can also modulate cytokine responses. Particularly they are involved in the up regulation of
IL-10 that leads to the down regulation of co-stimulatory surface molecules of macrophages
[108]. These properties contribute to induction of an anti-inflammatory environment, con‐
comitant with a strong inhibition of cellular proliferation. Also, carbohydrates linked to pro‐
Helminthic Infections and Asthma: Still a Challenge for Developing Countries
http://dx.doi.org/10.5772/54690
215
teins and lipids of nematodes, particularly those of phosphorylcholine (PC)-modified
carbohydrates [109] have attracted significant attention in the past years due to their immu‐
nogenic and immunomodulatory properties. Structural features of glycolipids including oli‐
gosaccharide backbone, substitution with PC, and ceramide composition are shared between
all the parasitic nematode species with widespread anatomical location in the worm [109]
suggesting the importance of these components in host parasite interactions. The secreted
filarial nematode glycoprotein ES-62 constitutes a suitable example. Through PC modifica‐
tions, ES-62 can inhibit the proliferation of CD4+ T cells and conventional B2 cells in vivo, and
reduces CD4+ cell IL-4 and IFN-γ production [110]. Conversely, ES-62 promotes proliferation
and IL-10 production by peritoneal B1 cells [111]. It has been proposed that inhibition of
proinflammatory Th1 responses occurs as ES-62 interacts with toll-like receptor (TLR) 4
through its PC residues [112], also in mast cells the interaction of TLR 4 with ES-62 results in
the inhibition of degranulation and release of inflammatory mediators [113]. On the other
hand, like proteins, glycolipids can be target of antibody responses. In the case of helminths
antibody reactivity to lipids has been described in schistosomiasis [114] and more recently in
A. lumbricoides infection [115]. Epidemiological studies using Ascaris derived glicolipids have
shown that children carrying heavy infections show highest IgG reactivity glycolipids com‐
pared to lightly or non-infected children [115]. In the same study IgG antibody reactivity to
both glyco proteins and glycolipids were directed to the PC moiety as determined by either
removal of this group or a competition assay suggesting that A. lumbricoides specific glycolipids
have antigenic properties. The mechanism by which glycolipids can stimulate IgE and IgG
responses is not clear. It is possible that antibodies could develop directly to glycolipids
through activation of CD1d which is a non classical MHC lipid presenting molecule. Never‐
theless, cross reactivity between glycolipids and PC present on proteins may also occur [115].
The immunomodulatory effects exhibited by PC- substituted molecules can be seen as a con‐
tribution to equilibrium in host -parasite interactions in which expanding of TH2 type re‐
sponses enables the parasite to survive preventing harmful pro-inflammatory mechanisms in
the host. Since PC substituted molecules from nematode differ clearly from those from the
host, they would be a suitable target for the development of new anti inflammatory drugs.
6. Future challenges and research perspectives
As mentioned above, the prevalence of asthma in rural developing countries has been under es‐
timated for many years and in many areas of the world in which persons with asthma do not
have access to basic asthma medications or medical care and are not included in any statistical
survey. Thus adequate control of asthma in developing countries would require improve‐
ments in health care and the development of technologies to obtain the information needed to
identify high-risk groups (disease mapping) [3]. This goal would be difficult to achieve if coun‐
tries do not allocate resources to enable better health care. On the other hand, since many years
several global efforts have been made to address the health effects of human parasitism by hel‐
minths which results from poverty and exert a well known detrimental impact on the health sta‐
tus of children continuously exposed to these parasites. The World Health Assembly (WHA)
Respiratory Disease and Infection - A New Insight216
has adopted several resolutions calling for the control or elimination of these diseases, and for
the implementation of a number of large-scale control and elimination programs. However, de‐
spite such WHA/WHO resolutions, the control of morbidity and the elimination of these infec‐
tions are still a big challenge for global health programs. Some of the identified obstacles include
the current scarcity of tools for updated disease mapping, the development of new anthelmin‐
tic drugs and vaccines, the improvement of sensitive diagnostic tools and the monitoring of the
progress of control interventions and quantification of changes in incidence of infection and dis‐
ease [116]. However and according to the WHA/WHO resolution, mass chemotherapy have
been widely implemented in rural areas of many developing countries in which sanitary limita‐
tions are far to be overcome [6]. Under these conditions, this approach would reduce worm bur‐
dens without elimination of the infection in endemic areas, which gradually will change the
profile of the infection from a chronic pattern, with moderate to heavy worm burdens [5] to a
more mild and seasonal pattern [5], thereby disrupting the regulatory, anti-inflammatory ef‐
fect of chronic infections on the immune response, allowing allergic sensitization in atopic par‐
asitized individuals [117, 118]. Thus, the development of diagnosis protocols facilitating rapid
identification of atopic individuals among rural populations is an immediate challenge to ach‐
ieve control of parasites without affecting the health status of a significant proportion of these
populations. On the other hand, the presence of respiratory symptoms as a consequence of in‐
flammation due to the parasite migratory phase in non atopic individuals [8] must also be con‐
sidered.  For  these  purposes,  large  birth  cohort  studies  designed  according  to  specific
epidemiological objectives and based on results from cross-sectional studies, small longitudi‐
nal and pilot intervention studies would help to elucidate the role of the many parameters in‐
volved in host- parasite interactions contributing to the pathogenesis of asthma. Also, the
identification of conserved features of helminth products that interact with innate immune cells
to co-ordinate adaptive anti-parasite responses as well as of potent parasite derived allergens is
a key challenge to improve the technology used in the diagnosis and monitoring of allergic dis‐
eases in the tropics. Noteworthy is the cross-reactivity of helminth antigens with environmen‐
tal  allergens which may explain the high prevalence of  IgE sensitization to invertebrate
allergens leading to the development of asthma and other allergic diseases [61]. Finally, the
identification and characterization of individual helminth-derived immunomodulatory mole‐
cules that selectively induce regulatory immune responses will provide potential candidates
for immunotherapy [119] and must be the subject for future research programs.
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